Kelly Carroll is a seasoned professional with extensive experience in mentoring, advising, and investing across various sectors, particularly in healthcare and technology. Currently serving as a mentor with SPARK Western Switzerland, Nucleate Switzerland, and the Innovation Office University of Basel, as well as an advisor for OrthoSens, Carroll actively supports the growth of innovative companies. Alongside roles as a member and investor at MEDKAP Investor Association, and as a business angel with Swiss Health Angels, Carroll is also a limited partner with Asymmetry Ventures, N49P Ventures, and LAUNCH, focusing on impactful investments. Previous leadership includes a role as Transition Leader during the Sandoz spinoff from Novartis, successfully overseeing asset separation and organizational establishment. Carroll's educational background includes an MBA from Alliance Manchester Business School and various executive programs at INSEAD and Duke Corporate Education.
This person is not in the org chart
This person is not in any teams
This person is not in any offices